Medical ozone induces proliferation and migration inhibition through ROS accumulation and PI3K/AKT/NF-κB suppression

J Li1, T Zeng2,3, S Tang1

  • 1Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong, People's Republic of China.

Abstract

Insights

Ozone therapy shows promise in fighting liver cancer by inhibiting cancer cell growth and migration. It works by increasing reactive oxygen species (ROS) and suppressing key cell signaling pathways.

Area of Science:

  • Oncology
  • Biochemistry
  • Cell Biology

Background:

  • Hepatocellular carcinoma is a major global health concern, causing significant mortality.
  • Ozone is being explored for its therapeutic potential across various medical conditions.

Purpose of the Study:

  • To investigate the anticancer effects of ozone on liver cancer cells.
  • To understand the underlying mechanisms of ozone's action.

Main Methods:

  • Utilized bel7402 and SMMC7721 liver cancer cell lines.
  • Assessed proliferation, colony formation, migration, cell cycle, and reactive oxygen species (ROS).
  • Measured glutathione levels and analyzed protein expression via Western blot.

Main Results:

  • Ozone inhibited liver cancer cell proliferation and colony formation.
  • Ozone induced G2/M phase cell cycle arrest and suppressed epithelial-mesenchymal transition (EMT).
  • Ozone increased ROS, decreased glutathione, and inactivated the PI3K/AKT/NF-κB pathway.

Conclusions:

  • Ozone restrains proliferation, migration, and EMT in liver cancer cells.
  • These effects are mediated by ROS accumulation and PI3K/AKT/NF-κB pathway suppression.
  • N-acetylcysteine pre-treatment reversed ozone's effects, confirming the role of ROS.